News

瑞德西韋用於治療 COVID-19 患者 (Remdesivir for the treatment of COVID-19)
Remdesivir for the treatment of COVID-19瑞德西韋（一種抗病毒藥物）是一種治療COVID-19 的有效方法嗎？關鍵信息• 對於因 COVID-19 住院的成年人，與安慰劑（假治療）或常規照護相比，瑞德西韋可能對治療後的任何原因導致的死亡（至第 28 天）影響很小甚至沒有影響。
Cochrane Hong Kong: 7th Pan-Pacific Nursing Conference Pre-Conference Workshops 1&2 (26th-27th May)
Organised by Cochrane Hong Kong for the 7th Pan-Pacific Nursing Conference, two 1-day and 2-day pre-conference workshops on ‘Interpreting systematic reviews and using Cochrane Reviews’ and ‘Systematic Reviews and Evidence Synthesis’ were successfully held from 26th to 27th May!
Cochrane Hong Kong will hold two workshops on 26-27 May 2021
Cochrane Hong Kong will hold two workshops on 26-27 May 2021 as the pre-conference workshops of the Seventh Pan-Pacific Nursing Conference. The objectives of the workshops are to enable participants to understand and interpret systematic reviews and meta-analyses and to equip participants with knowledge and skills in planning and conducting Cochrane Reviews. 
用於診斷SARS-CoV-2感染的快速即時抗原和分子檢測 (Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection)
Updated Cochrane review assesses how accurate rapid tests are for detecting COVID-19.
阻斷白細胞介素-6（interleukin-6; 一種參與免疫應答的蛋白質）的藥物能否治療COVID-19？(Can medicines that block interleukin-6 (a protein involved in immune responses) treat COVID-19?)
Can medicines that block interleukin-6 (a protein involved in immune responses) treat COVID-19?用Tocilizumab（一種阻斷白細胞介素-6的藥物）治療COVID-19可以減少治療后28天內死亡的人數，而且導致的嚴重不良事件數目可能比安慰劑治療組更少。 目前正在研究能阻斷白細胞介素-6的其他藥物治療COVID-19的效果。 綜述作者將在獲得其他研究的結果后對本綜述進行更新。 
哪種類型的心臟和血管問題會使COVID-19感染複雜化？ 這些問題有多常見？ 這些患者還有哪些其他疾病？(What type of heart and blood vessel problems complicate COVID‐19 infections, how common are they and what other medical conditions do these patients have?)
What type of heart and blood vessel problems complicate COVID‐19 infections, how common are they and what other medical conditions do these patients have?研究背景
戒煙與心理健康改善有關 (Featured Review: Stopping smoking is linked to improved mental health)
Cochrane Review finds stopping smoking is linked to improved mental health.今天發表在Cochrane圖書館的證據將再次鼓勵想要戒煙的人，戒煙至少6周可以改善他們的精神健康，減少焦慮、抑鬱和壓力。 人們的社會關係不大可能受到戒煙的影響。 吸煙是世界上導致可預防性疾病和死亡的首要原因。 每兩個吸煙者中就有一個會死於與吸煙有關的疾病，除非他們戒煙。 一些人認為，吸煙有助於減輕壓力和其他心理健康癥狀，戒煙可能會使他們的心理健康問題惡化。 吸煙的人也擔心戒煙會對他們的社會生活和交友產生負面影響。 
確定在初級保健或醫院門診就診的患者是否患有COVID-19的體征和癥狀（Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19）
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19
Cochrane expands its reach with the launch of a new Network across China
Today Cochrane announces the official launch of a new network of institutions committed to promote evidence-based health care practice and policy decision making in China.
Official Launch of Cochrane China Network
The Cochrane China Network has recently been established to represent Cochrane and support evidence-based health care practice and policy decision making in China. The Official Launch Meeting of Cochrane China Network will be held on 21-22 January 2021 in a virtual mode.